Ebola hemorrhagic fever outbreaks: strategies for effective epidemic management, containment and control.
Matua GA, Van der Wal DM, Locsin RC.
Braz J Infect Dis. 2015 May-Jun;19(3):308-13. doi: 10.1016/j.bjid.2015.02.004. Epub 2015 Apr 17.
Ebola virus disease: A narrative review.
Letafati A, Salahi Ardekani O, Karami H, Soleimani M.
Microb Pathog. 2023 Aug;181:106213. doi: 10.1016/j.micpath.2023.106213. Epub 2023 Jun 23.
Ebola hemorrhagic Fever.
Burnett MW.
J Spec Oper Med. 2014 Fall;14(3):93-94. doi: 10.55460/JBMR-T6LY.
Ebola Virus Disease: Epidemiology, Clinical Features, Management, and Prevention.
Nicastri E, Kobinger G, Vairo F, Montaldo C, Mboera LEG, Ansunama R, Zumla A, Ippolito G.
Infect Dis Clin North Am. 2019 Dec;33(4):953-976. doi: 10.1016/j.idc.2019.08.005.
Ebola hemorrhagic fever: genetic biomarkers and vaccine development.
Oliphant E.
Genet Test Mol Biomarkers. 2014 Nov;18(11):715-6. doi: 10.1089/gtmb.2014.1560. Epub 2014 Oct 23.
[Ebola hemorrhagic fever].
Sata T.
Nihon Rinsho. 2007 Mar 28;65 Suppl 3:25-9.
Ebola haemorrhagic fever.
Feldmann H, Geisbert TW.
Lancet. 2011 Mar 5;377(9768):849-62. doi: 10.1016/S0140-6736(10)60667-8.
The pathogenesis of Ebola hemorrhagic fever.
Takada A, Kawaoka Y.
Trends Microbiol. 2001 Oct;9(10):506-11. doi: 10.1016/s0966-842x(01)02201-6.
[Ebola hemorrhagic fever: its extension reflects the African sanitary disaster].
Bourée P.
Rev Prat. 2014 Sep;64(7):905-10.
Pharmacotherapy of Ebola hemorrhagic fever: a brief review of current status and future perspectives.
Olszanecki R, Gawlik G.
Folia Med Cracov. 2014;54(3):67-77.
